Home
Search
Search Results
Previously Searched
3167 results found
Expand All
Apply All
3167 results found

Good Day BIO: Price controls would 'devastate' medical innovation
Good Day BIO Newsletter  •  August 1, 2022
A new week, a new month—and the last week the Senate’s in session before the August recess. We’ll be keeping an eye on what happens with the “slimmed down” Build Back Better, which includes anti-science drug price controls. Meanwhile, we’re worried about the heat—but we should also be worried about soil, says the UN. (651 words, 3 minutes, 15 seconds)
Read More

CSBA Sends Letter to Congressional Leadership on Negative Impacts of Democrats' Drug Pricing Proposal
Human Health, Council for State Biotechnology Associations (CSBA)  •  Letters, Testimony & Comments  •  July 29, 2022
The Council of State Bioscience Associations (CSBA) is an alliance of independent, state and territory based, non-profit trade associations, each of which advocates for public policies that support responsible development and delivery of innovative life-enhancing and life-saving biotechnology solutions. We write today to express our serious concerns about the proposals included in the recently released Senate Democrats’ drug pricing proposals, which will devastate that innovation. Most of our biopharmaceutical member companies are small-to-medium in size and relatively few have products on the market. Yet, these companies are leading the world in cutting edge research to develop new therapies and cures, including gene and cell therapies, and of course, vaccines and treatments for COVID-19.
Read More

Good Day BIO: New study says price controls devastate drug R&D, patient access
Good Day BIO Newsletter  •  July 29, 2022
With drug price controls under consideration in the Senate, new analysis shows how they would devastate drug development and new treatments. On World Hepatitis Day, we look at why this preventable, treatable virus is still a threat. (740 words, 3 minutes, 42 seconds) P.S. The BIO Impact Agriculture & Environment conference is right around the corner. Be sure to register today.
Read More

Good Day BIO: USTR nominee would use ‘every tool’ to enforce USMCA biotech provisions
Good Day BIO Newsletter  •  July 28, 2022
Ending the week with what USTR nominee Doug McKalip said about agricultural biotech trade with Mexico and Korea, plus a new report that shows the dire need to invest in public health infrastructure and preparedness. (783 words, 3 minutes, 54 seconds)
Read More

Good Day BIO: State Medicaid policies can interfere with access to new treatments, says report
Good Day BIO Newsletter  •  July 27, 2022
A new report finds the patchwork of state regulations regarding Medicaid coverage for new, innovative treatments can create barriers for patients seeking access to the most advanced therapies. Meanwhile, it’s getting hotter on Earth—and biotech is helping us explore new possibilities for growing food in space. (774 words, 3 minutes, 52 seconds)
Read More

Good Day BIO: Why we need to focus on the value of care
Good Day BIO Newsletter  •  July 26, 2022
With everyone talking about drug pricing, we have an exclusive look at why we need to think about value rather than cost. Plus, we’re celebrating Dr. Rosalind Franklin’s birthday—and looking for the next biotech game-changers. (699 words, 3 minutes, 29 seconds)
Read More

Good Day BIO: WHO declares monkeypox a 'health emergency'
Good Day BIO Newsletter  •  July 25, 2022
Over the weekend, WHO declared monkeypox a health emergency of international concern—we tell you what that means and what’s happening in the U.S. Plus, recent CBO analysis of proposed drug price controls misinforms—and misses the mark, say BIO’s health policy experts. (682 words, 3 minutes, 24 seconds)
Read More

Good Day BIO: BARDA funding and animal feed
Good Day BIO Newsletter  •  July 22, 2022
Before the weekend, we have a quick read on why we need to fund BARDA and what the FDA Commissioner said about animal feed. (538 words, 2 minutes, 41 seconds)
Read More

Nebraska Governor Pete Ricketts to Headline BIO’s Impact Ag & Environment Conference in Omaha
Agriculture & Environment  •  Press Release  •  July 21, 2022
BIO is hosting the Impact Ag & Environment Conference, in-person for the first time in three years, in Omaha, Neb., Sept. 19-21, 2022. Headlined by Nebraska Gov. Pete Ricketts, the event will convene leaders across the bioeconomy whose cutting-edge companies are using science to tackle some of our world’s most pressing challenges—from food security to climate, supply chains to energy security, and more. Members of the media are invited to register and attend. What: The BIO Impact Ag & Environment Conference is the premier gathering of global biotech leaders for three days of discussion, partnering and networking to advance the role of science in enhancing agriculture and improving the environment. BIO Communications is available to help with connecting with companies and speakers and setting up interviews. When:  Mon., Sept. 19, – Wed., Sept. 21, 2022   Three plenary sessions, including remarks by Nebraska Gov. Pete Ricketts Local company site tours Over a dozen breakout sessions on growing trust in scientific innovation, expanding the bioeconomy, and mitigating climate change Start-Up Stadium presentations by up-and-coming biotech companies and technologies Exhibit hall featuring the latest technologies and leading companies Where: CHI Health Center, 455 N. 10th St., Omaha, NE 68102 Why: The Impact Ag & Environment Conference is the place to learn more about how today’s biotech innovations are leading to tomorrow’s impact. Click here to register for media credentials.  BIO offers complimentary media registration to editors and reporters working for print, broadcast, or web publications with valid press credentials.
Read More

Good Day BIO: House passes Ag-FDA spending bill that boosts biotech
Good Day BIO Newsletter  •  July 21, 2022
It was a busy Wednesday. The House passed the Ag-FDA spending bill, which boosts biotech and innovation. Two U.S. Senators (and Dr. Michelle) discussed how and why we need to tackle antimicrobial resistance. Plus, BIO responded to the Berlin Declaration on vaccine access. (764 words, 3 minutes, 49 seconds)
Read More